Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Hi-ClearanceROCO:1788 79 FCF Yield % is 4.81 as of Jul. 24, 2026, which is at its 10-year median of 4.81. GuruFocus rates ROCO:1788 with a GF Score™ of 79/100 and a GF Value™ of NT$138.61 (Fairly Valued). The stock has 4 warning signs investors should review. Among 853 Medical Devices & Instruments companies, Hi-Clearance ranks better than 80.07% on this metric.
FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.
The historical rank and industry rank for Hi-Clearance's FCF Yield % or its related term are showing as below:
ROCO:1788'
s FCF Yield % Range Over the Past 10 Years
Min: -3.37 Med: 4.81 Max: 9.76
Current: 4.81
During the past 13 years, the highest FCF Yield % of Hi-Clearance was 9.76%. The lowest was -3.37%. And the median was 4.81%.
ROCO:1788's FCF Yield % is ranked better than 80.07% of 853
companies
in the Medical Devices & Instruments industry
Industry Median: -0.42
vs ROCO:1788: 4.81
Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.
Hi-Clearance FCF Yield % Related Terms
Hi-Clearance FCF Yield % Historical Data
* Premium members only.
The historical data trend for Hi-Clearance's FCF Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ROCO:1788 vs ABT, SYK, MDT: FCF Yield % Comparison
For the Medical Devices subindustry, Hi-Clearance's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Hi-Clearance FCF Yield % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Hi-Clearance's FCF Yield % distribution charts can be found below:
* The bar in red indicates where Hi-Clearance's FCF Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Hi-Clearance (ROCO:1788) has a FCF Yield % of 4.81 as of Jul. 24, 2026. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on Hi-Clearance and its competitors. This is near median its historical median of 4.81. According to the industry distribution chart, Hi-Clearance ranks #170 out of 853 companies in the Medical Devices & Instruments industry, placing it in the top 19.9%.
Is Hi-Clearance's FCF Yield % too high?
Hi-Clearance's current FCF Yield % of 4.81 is near median its 10-year median of 4.81. Based on the distribution chart, Hi-Clearance ranks #170 out of 853 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Hi-Clearance has a GF Score™ of 79/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Hi-Clearance's FCF Yield % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Hi-Clearance ranks #170 out of 853 companies for FCF Yield %. This places Hi-Clearance in the top 20% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Yield % for a Medical Devices & Instruments company?
A good FCF Yield % depends on the Medical Devices & Instruments industry context. However, FCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Yield % mean?
A high FCF Yield % can signal that a stock is expensive relative to its fundamentals. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on Hi-Clearance and its competitors. Hi-Clearance's current FCF Yield % is 4.81, which is near median its own 10-year median of 4.81. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Hi-Clearance stock overvalued right now?
Based on GuruFocus' analysis, Hi-Clearance (ROCO:1788) is currently considered Fairly Valued. The stock's GF Value™ is NT$138.61, compared to a current price of NT$129.50 — trading 6.6% below its estimated fair value. The current FCF Yield % is 4.81, which is near median its 10-year median of 4.81. Hi-Clearance's overall GF Score™ is 79/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Yield % calculated?
FCF Yield % is calculated from a company's financial statements. For Hi-Clearance (ROCO:1788), the current FCF Yield % is 4.81 as of Jul. 24, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Hi-Clearance (ROCO:1788) Overvalued in 2026?
Based on GuruFocus' analysis, Hi-Clearance stock appears to be undervalued.
The current stock price of NT$129.50 is trading 6.6% below its estimated GF Value™ of NT$138.61.
GuruFocus considers Hi-Clearance to be Fairly Valued.
Key valuation signals for ROCO:1788:
FCF Yield %: 4.81 (near median its 10-year median of 4.81)
GF Value™: NT$138.61 vs. price of NT$129.50 (6.6% below fair value)
No single metric tells the full story. See the ROCO:1788 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Hi-Clearance Inc primary business activities involve trading medical equipment, biochemical reagents, and Western medicine. It has two segments Hemodialysis Division responsible for the procurement and distribution of a wide range of blood dialysis-related consumables, which are sold to hospitals, clinics, and distributors; and Other business segments mainly involved in selling dental materials and other products. The company generates majority of revenue from Hemodialysis Division. Its products are Single Patient Dialysis System TORAY, TORAYLIGHT Hollow Fiber Dialyzer, FILTRYZER TORAY, TORAY ETRF.
79GF Score
Get the complete analysis for ROCO:1788
FCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROCO:1788 has been successfully added to your 
